Profiles of 18 Domestic Chinese Pharmaceutical Companies Point to Opportunities

Cary, N.C. – June 9, 2011 – Industry Standard Research (ISR) today announced the launch of a new and substantial research report titled “Domestic Chinese Pharmaceutical Companies: Competitor, Complementor, or Catalyst” This report profiles 18 of the largest and fastest-growing domestic Chinese pharmaceutical companies by examining their corporate structure, current products, therapeutic areas of focus, … Continued